Matches in SemOpenAlex for { <https://semopenalex.org/work/W4366772199> ?p ?o ?g. }
- W4366772199 endingPage "2394" @default.
- W4366772199 startingPage "2394" @default.
- W4366772199 abstract "Background: Prognostic and predictive factors for patients with metastatic renal cell carcinoma (mRCC) treated with immunotherapy are highly warranted, and the immune tumor microenvironment (I-TME) is under investigation. Methods: The Meet-URO 18 was a multicentric retrospective study assessing the I-TME in mRCC patients treated with ≥2nd-line nivolumab, dichotomized into responders and non-responders according to progression-free survival (≥12 months and ≤3 months, respectively). The primary objective was to identify differential immunohistochemical (IHC) patterns between the two groups. Lymphocyte infiltration and the expressions of different proteins on tumor cells (CD56, CD15, CD68, and ph-mTOR) were analyzed. The expression of PD-L1 was also assessed. Results: A total of 116 tumor tissue samples from 84 patients (59% were primary tumors and 41% were metastases) were evaluated. Samples from responders (N = 55) were significantly associated with lower expression of CD4+ T lymphocytes and higher levels of ph-mTOR and CD56+ compared with samples from non-responders (N = 61). Responders also showed a higher CD3+ expression (p = 0.059) and CD8+/CD4+ ratio (p = 0.084). Non-responders were significantly associated with a higher percentage of clear cell histology and grading. Conclusions: Differential IHC patterns between the tumors in patients who were responders and non-responders to nivolumab were identified. Further investigation with genomic analyses is planned." @default.
- W4366772199 created "2023-04-25" @default.
- W4366772199 creator A5005499943 @default.
- W4366772199 creator A5007550747 @default.
- W4366772199 creator A5012423170 @default.
- W4366772199 creator A5013913173 @default.
- W4366772199 creator A5015859129 @default.
- W4366772199 creator A5018858868 @default.
- W4366772199 creator A5023848359 @default.
- W4366772199 creator A5028388712 @default.
- W4366772199 creator A5030345469 @default.
- W4366772199 creator A5033351253 @default.
- W4366772199 creator A5034433849 @default.
- W4366772199 creator A5045717411 @default.
- W4366772199 creator A5049304290 @default.
- W4366772199 creator A5049850318 @default.
- W4366772199 creator A5050343624 @default.
- W4366772199 creator A5050786772 @default.
- W4366772199 creator A5064692941 @default.
- W4366772199 creator A5065054377 @default.
- W4366772199 creator A5073052848 @default.
- W4366772199 creator A5073522960 @default.
- W4366772199 creator A5075751160 @default.
- W4366772199 creator A5077883336 @default.
- W4366772199 creator A5080840934 @default.
- W4366772199 creator A5081355165 @default.
- W4366772199 creator A5081853149 @default.
- W4366772199 creator A5082704939 @default.
- W4366772199 date "2023-04-21" @default.
- W4366772199 modified "2023-10-18" @default.
- W4366772199 title "Characterization of Tumor and Immune Tumor Microenvironment of Primary Tumors and Metastatic Sites in Advanced Renal Cell Carcinoma Patients Based on Response to Nivolumab Immunotherapy: Preliminary Results from the Meet-URO 18 Study" @default.
- W4366772199 cites W1740043878 @default.
- W4366772199 cites W2029229070 @default.
- W4366772199 cites W2222086386 @default.
- W4366772199 cites W2547310148 @default.
- W4366772199 cites W2735932253 @default.
- W4366772199 cites W2792656817 @default.
- W4366772199 cites W2810919053 @default.
- W4366772199 cites W2887790253 @default.
- W4366772199 cites W2962989894 @default.
- W4366772199 cites W2974122860 @default.
- W4366772199 cites W2981212944 @default.
- W4366772199 cites W3042364418 @default.
- W4366772199 cites W3118551423 @default.
- W4366772199 cites W3135213711 @default.
- W4366772199 cites W3135540822 @default.
- W4366772199 cites W3158086066 @default.
- W4366772199 cites W3158664191 @default.
- W4366772199 cites W3162155070 @default.
- W4366772199 cites W3191302681 @default.
- W4366772199 cites W3205023491 @default.
- W4366772199 cites W3214557353 @default.
- W4366772199 cites W3214736212 @default.
- W4366772199 cites W4224324694 @default.
- W4366772199 cites W4225282867 @default.
- W4366772199 cites W4281668773 @default.
- W4366772199 cites W4288885931 @default.
- W4366772199 cites W4310773806 @default.
- W4366772199 cites W4313244066 @default.
- W4366772199 doi "https://doi.org/10.3390/cancers15082394" @default.
- W4366772199 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37190322" @default.
- W4366772199 hasPublicationYear "2023" @default.
- W4366772199 type Work @default.
- W4366772199 citedByCount "0" @default.
- W4366772199 crossrefType "journal-article" @default.
- W4366772199 hasAuthorship W4366772199A5005499943 @default.
- W4366772199 hasAuthorship W4366772199A5007550747 @default.
- W4366772199 hasAuthorship W4366772199A5012423170 @default.
- W4366772199 hasAuthorship W4366772199A5013913173 @default.
- W4366772199 hasAuthorship W4366772199A5015859129 @default.
- W4366772199 hasAuthorship W4366772199A5018858868 @default.
- W4366772199 hasAuthorship W4366772199A5023848359 @default.
- W4366772199 hasAuthorship W4366772199A5028388712 @default.
- W4366772199 hasAuthorship W4366772199A5030345469 @default.
- W4366772199 hasAuthorship W4366772199A5033351253 @default.
- W4366772199 hasAuthorship W4366772199A5034433849 @default.
- W4366772199 hasAuthorship W4366772199A5045717411 @default.
- W4366772199 hasAuthorship W4366772199A5049304290 @default.
- W4366772199 hasAuthorship W4366772199A5049850318 @default.
- W4366772199 hasAuthorship W4366772199A5050343624 @default.
- W4366772199 hasAuthorship W4366772199A5050786772 @default.
- W4366772199 hasAuthorship W4366772199A5064692941 @default.
- W4366772199 hasAuthorship W4366772199A5065054377 @default.
- W4366772199 hasAuthorship W4366772199A5073052848 @default.
- W4366772199 hasAuthorship W4366772199A5073522960 @default.
- W4366772199 hasAuthorship W4366772199A5075751160 @default.
- W4366772199 hasAuthorship W4366772199A5077883336 @default.
- W4366772199 hasAuthorship W4366772199A5080840934 @default.
- W4366772199 hasAuthorship W4366772199A5081355165 @default.
- W4366772199 hasAuthorship W4366772199A5081853149 @default.
- W4366772199 hasAuthorship W4366772199A5082704939 @default.
- W4366772199 hasBestOaLocation W43667721991 @default.
- W4366772199 hasConcept C121608353 @default.
- W4366772199 hasConcept C126322002 @default.
- W4366772199 hasConcept C143998085 @default.
- W4366772199 hasConcept C167672396 @default.
- W4366772199 hasConcept C203014093 @default.
- W4366772199 hasConcept C204232928 @default.